Trial Profile
Master Rollover Protocol for Continued Safety Assessment of Study Drug
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 20 Aug 2021
Price :
$35
*
At a glance
- Drugs LY 2503029 (Primary)
- Indications Cancer
- Focus Expanded access; Therapeutic Use
- Sponsors Eli Lilly and Company
- 23 Dec 2015 New trial record